Users Stopping Anti-Obesity Injections Put On Weight at a Quadrupled Rate Than Dieters

Fresh analysis indicates that individuals who stop using blockbuster slimming jabs like Wegovy and Mounjaro may regain shed pounds much more quickly than those who end traditional diet and exercise plans.

Research printed in a leading medical journal shows that while overweight people often shed substantial amounts of their total mass while undergoing treatment, the mass is regained at an average rate of nearly a kilo each month upon discontinuation.

"Users purchasing these treatments must be aware of the risk of fast rebound weight gain when the therapy concludes," warns lead investigator Dr. Susan Jebb.

That rate of recovery means a reversion to pre-treatment weight within about a year and a half.

Analyzing Therapies

The analysis, which looked at 37 of studies involving thousands of patients, compared the outcomes of these new drugs with other pills.

The team point out that individuals who lose weight through lifestyle changes alone generally see a slower weight regain—around 0.1 kg a month—post-intervention.

Explaining the Fast Rebound

Experts propose the way of the injections is key to understanding the heightened weight return.

GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which moderates hunger.

"Sustained high doses of the hormone levels far above than the body's typical production might result in the system to produce less of its endogenous hormone, and could lessen responsiveness to its actions," explained Dr. Adam Collins, a dietetics expert.

"Discontinuation of this medication leads to appetite is no longer kept in check, making binge eating a significant risk."

An Ongoing Condition?

The NHS recommend the injections for people with obesity-related health risks, accompanied by recommended lifestyle changes.

Professionals say that, due to the significant potential of relapse, the therapy should be considered ongoing.

This opinion is reinforced by pharmaceutical companies, who say that the results "emphasize the long-term character of obesity," comparing it to managing diseases like high blood pressure.

Patient Experiences

People who have discontinued the medication explain a intense return of appetite.

"It felt as if a switch that goes on and you're instantly starving," described an individual.

This challenge is exacerbated if individuals have not adopted lasting lifestyle or habit changes during treatment.

Growing Use

Survey data suggest that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with desire continuing to grow.

• Use is more common among females than males.
• The 40s and 50s age group shows the highest usage rates.
• A large proportion access the drugs through private healthcare rather than the NHS.

In conclusion, experts stress that while these medications are effective tools for shedding pounds, they are not a permanent solution and maintained weight loss likely depends on integrated lifestyle support.